Nitrate-augmented myocardial imaging for assessment of myocardial viability

²⁰¹Tl myocardial perfusion imaging is presently done by several possible strategies. Stress/delayed redistribution, stress/redistribution/reinjection, and rest/redistribution imaging can be useful in the clinical assessment of myocardial viability. Unfortunately, the extent of myocardial viability may still be underestimated even by ²⁰¹Tl reinjection imaging, compared with ¹⁸F-fluorodeoxyglucose positron emission tomography. ^99mTc-labeled sestamibi imaging provides results similar to those of ²⁰¹Tl imaging in the detection of coronary artery disease, but several previous studies suggest that stress/rest ^99mTc-labeled sestamibi imaging significantly underestimates myocardial viability. Recently it has been reported that the administration of nitrates, before ²⁰¹Tl reinjection, improves detection of defect reversibility. Several studies also suggested that administration of nitrates before the injection of ^99mTc-labeled sestamibi significantly improved detection of reversibility with this agent, whereas additional studies showed further that this combination improves the predictive accuracy for recovery of left ventricular function and perfusion after coronary revascularization, compared with a standard rest ^99mTc-labeled sestamibi study. Nitrate administration before the injection of ²⁰¹Tl and ^99mTc-labeled sestamibi may thus be a potentially attractive alternative for the evaluation of myocardial viability. Although the available results are encouraging, further studies are needed to evaluate the clinical value of ²⁰¹Tl and ^99mTc-labeled sestamibi imaging, in combination with nitrates, for predicting recovery of left ventricular dysfunction.     

Comparative accuracy of various Tl-201 reinjection imaging protocols to detect myocardial viability

The conventional exercise-3 hours-redistribution thallium-201 [²⁰¹Tl] imaging protocol has been recognized to be suboptimal for reliable detection of myocardial viability. Although²⁰¹Tl restreinjection after exercise has improved detection of viable myocardium, it is still underestimated in some patients. The present study was designed to compare detection of viable myocardium in five separate imaging steps: step 1: initial-exercise imaging, step 2: delayed-exercise imaging, step 3: Tl-201 reinjection imaging after delayed-exercise imaging, step 4: separate day rest-reinjection imaging, and step 5: separate day delayed-rest imaging. The study group consisted of 22 patients scheduled for coronary revascularization (either percutaneous transluminal coronary angioplasty or coronary bypass surgery). Pre- and postintervention echocardiographic wall motion and thickness served as independent markers of myocardial viability. Results: Accuracy in identifying myocardial viability gradually improved incrementally from²⁰¹Tl imaging step 1 to step 5. The positive predictive value, negative predictive value and overall accuracy were best for the separate day delayed-rest study (step 5) at 90%, 33% and 78%, respectively. Myocardial segments had fixed defects on separate day delayed-rest²⁰¹Tl imaging (step 5), but nevertheless echocardiographic evidence of myocardial viability indicated less severe defects than segments judged non viable by echocardiography (p = 0.021). The overall accuracy of separate day delayed-rest imaging (step 5) in predicting viability improved to 88% when segments with moderate or mild defects were considered viable. In conclusion, the most reliable predictor of myocardial viability with²⁰¹Tl imaging is defect severity on separate day delayed-rest images.     

Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography

The detection of preserved glucose uptake in hypoperfused dysfunctional myocardium by fluorine-18 deoxyglucose (FDG) positron emission tomography (PET) represents the method of choice in myocardial viability diagnostics. As the technique is not available for the majority of patients due to cost and the limited capacity of the PET centres, it was the aim of the present work to develop and test FDG single-photon emission tomography (SPET) with the means of conventional nuclear medicine. The perfusion marker sestamibi (MIBI) was used together with the metabolic tracer FDG in dual-isotope acquisition. A conventional SPET camera was equipped with a 511-keV collimator and designed to operate with simultaneous four-channel acquisition. In this way, the scatter of 18F into the technetium-99m energy window could be taken into account by a novel method of scatter correction. Thirty patients with regional wall motion abnormalities at rest were investigated. The results of visual wall motion analysis by contrast cine-ventriculography in nine segments/heart were compared with the results of quantitative scintigraphy. The scintigraphic patterns of MIBI and FDG tracer accumulation were defined as normal, matched defects and perfusion-metabolism mismatches. Spatial resolution of the system was satisfactory, with a full width at half maximum (FWHM) of 15.2 mm for ¹⁸F and 14.0 mm for ^99mTe, as measured by planar imaging in air at 5 cm distance from the collimator. Image quality allowed interpretation in all 30 patients. 88% of segments without relevant wall motion abnormalities presented normal scintigraphic results. Seventy-five akinetic segments showed mismatches in 27%, matched defects in 44% and normal perfusion in 29%. We conclude that FDG-MIBI dual-isotope SPET is technically feasible with the means of conventional nuclear medicine. Thus, the method is potentially available for widespread application in patient care and may represent an alternative to the ²⁰¹T1 reinjection technique.     

Thallium-201 reinjection images can identify the viable and necrotic myocardium similarly to metabolic imaging with glucose loading18F-fluorodeoxyglucose (18FDG)-PET

We compared the usefulness of¹⁸F-fluorodeoxyglucose (¹⁸FDG)-PET with glucose loading and thallium-201 (²⁰¹Tl) reinjection imaging for determining the viability of the myocardium in 21 patients with an old anterior myocardial infarction. We obtained transaxial views during²⁰¹T1 reinjection imaging performed 10 minutes after post-exercise injection of 37 MBq²⁰¹Tl. PET imaging with 75 g oral glucose loading was performed 60 min after injection of 148 MBq of I8FDG. Wall motion was evaluated by echocardiography. Excellent¹⁸FDG-PET images were obtained in 19 of 21 subjects in whom plasma glucose levels were below 251 mg/d/. The results of²⁰¹Tl reinjection imaging and¹⁸FDG-PET imaging were in agreement in 20 of the 21 subjects. Echocardiography demonstrated hypokinesis or akinesis in segments identified as abnormal in imaging studies. Our results showed that²⁰¹Tl reinjection imaging identified the viable and necrotic myocardium similarly to metabolic imaging obtained by¹⁸FDG-PET with glucose loading.     

Comparison of exercise-rest-reinjection Tl-201 imaging and rest sublingual isosorbide dinitrate Tc-99m MIBI imaging for the assessment of myocardial viability

Purpose  Nitrate administration has been proposed to enhance the detection of myocardial viability when performing myocardial perfusion imaging. In this study, we aimed to compare Tl-201 exercise-rest-reinjection protocol with rest isosorbide dinitrate (ISDN)-Tc99m MIBI study in the same population examined for the myocardial viability. Methods  Twenty-six patients with coronary artery disease who had fixed segmental defects on exercise-rest-Tl-201 imaging were studied. All of them underwent Tl-201 reinjection study. Within 1 week of Tl-201 imaging, rest-Tc99m MIBI imaging was performed after sublingual 5 mg ISDN administration (2-day protocol). For each study, tomograms were divided into 20 segments based on three short-axis slices, one vertical long-axis representing the totality of the left ventricle and regional tracer uptake was quantitatively analyzed. Regional tracer uptake was evaluated in 20 myocardial segments for all patients. Viability was defined as presence of tracer uptake ≥50% of peak activity on each study. A total 520 myocardial segments were assessed by semi quantitative analysis. Result  On the baseline rest Tl-201 studies, 211 segments of the 520 segments that were analyzed had <50% of peak activity. Of these segments, 42 (20%) showed reversibility after reinjection Tl-201 imaging and 55 segments (27%) described as viable on the rest ISDN-Tc99m MIBI imaging. There was 89% concordance between the ISDN-Tc99m MIBI study and Tl-201 reinjection study regarding viable myocardial segments. Of the 23 segments with discordant results, 18 were irreversible on Tl-201 reinjection study, but showed ≥50% uptake on ISDN-Tc99m MIBI. Conclusion  Observation of good agreement between Tl-201 reinjection and ISDN-Tc99m MIBI study studies led us to suggest the use of ISDN enhanced imaging in the evaluation of myocardial viability.     

Attenuation correction improves the detection of viable myocardium by thallium-201 cardiac tomography in patients with previous myocardial infarction and left ventricular dysfunction

The aim of this study was to determine the influence of attenuation-corrected thallium-201 stress/redistribution/reinjection single-photon emission tomography (SPET) on the number of viable segments in patients with previous myocardial infarction and dysfunctional myocardium. Fifty-one patients with previous myocardial infarction and left ventricular dysfunction were included in the study. In all patients, ²⁰¹Tl non-corrected (NC) and attenuation-corrected (AC) SPET was performed using a stress/redistribution/reinjection protocol followed by coronary angiography. A semiquantitative analysis was performed using polar maps for NC and AC stress, redistribution and reinjection short-axis and vertical long-axis (apex) slices. Severe (perfusion defect below 50%/maximal count rate: PD_<50), mild and moderate persistent defects for redistribution and reinjection were evaluated for both NC and AC studies. A total of 1581 segments were evaluated by semiquantitative segmental analysis for both NC and AC studies for each redistribution and reinjection map. In the redistribution maps, NC revealed a total of 352 segments and AC a total of 222 segments with impaired perfusion below 50% of the maximal count rate (PD_<50). The mean number of affected segments was 6.9±5.5 in the case of NC and 4.4±4.8 in the case of AC (P<0.001). In the reinjection maps, NC revealed a total of 263 non-viable segments (PD_<50) and AC a total of 169 non-viable segments. The mean number of affected segments was 5.2±5.3 in the case of NC and 3.3±4.2 in the case of AC (P<0.001). Recovery of function was better predicted by AC than by NC in 20% of patients in the follow-up group. Therefore, the use of attenuation correction influences the extent of viable segments by showing more viable segments in either redistribution or reinjection maps. ²⁰¹Tl imaging without attenuation correction may underestimate the extent of tissue viability, which may contribute to the lower sensitivity compared to fluorine-18-fluorodeoxyglucose positron emission tomography, where attenuation correction is a routinely performed procedure. Received 26 October and in revised form 23 December 1998     

Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease

We compare thallium-201 rest redistribution and fluorine-18 fluorodeoxyglucose ([¹⁸F]FDG) for the assessment of myocardial viability within technetium-99m methoxyisobutylisonitrile (MIBI) perfusion defects in 27 patients with chronic stable coronary artery disease. The following studies were performed: (1) stress^99mTc-MIBI, (2) rest^99mTc-MIBI, (3)²⁰¹T1 rest-redistribution single-photon emission tomography, (4) [¹⁸F]FDG positron emission tomography. The left ventricle was devided into 11 segments on matched tomographic images. The segment with the highest activity at stress was taken as the reference (activity=100%). Perfusion defects at^99mTc-MIBI rest were classified as severe (activity<50%), moderate (activity 50%–60%) or mild (activity 60%–85%). Uptakes of [¹⁸F]FDG and rest-redistributed²⁰¹Tl were recognized as significant if they exceeded 50% of that in the reference segment. Among the 33 segments with severe^99mTc-MIBI rest perfusion defects, 21 had significant [¹⁸F]FDG and 10 significant rest-redistributed²⁰¹Tl uptake. As regards the 37 segments with moderate defects, [¹⁸F]FDG was present in 29 and²⁰¹Tl in 31, while of the 134 segments with mild defects, 128 showed [¹⁸F]FDG uptake, and 131,²⁰¹Tl uptake. In conclusion, there is an inverse relationship between the severity of^99mTc-MIBI perfusion defects and the uptake of rest-redistributed²⁰¹Tl and [¹⁸F]FDG. Both tracers are adequate markers of viability in mild and moderate defects; in severe defects²⁰¹Tl might underestimate the presence of viability as assessed by [¹⁸F]FDG.     

Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.

The aim of this study was to compare nonfluoroscopic electroanatomic mapping (NOGA), SPECT perfusion imaging, and PET metabolic imaging for assessment of myocardial viability. In particular, we sought to elucidate differences of electromechanical properties between the perfusion/metabolism mismatch as an indicator of a potentially reversible ischemic injury and the perfusion/metabolism match indicating irreversibly damaged myocardial tissue. METHODS: Twenty-one patients with coronary artery disease underwent NOGA mapping of endocardial unipolar voltage, cardiac 18F-FDG PET of glucose utilization, and resting 201Tl SPECT of myocardial perfusion. RESULTS: Electrical activity was 10.8 +/- 4.6 mV (mean +/- SD) in normal myocardium and was unchanged in hypoperfused segments with maintained glucose metabolism (perfusion/metabolism mismatch), 9.3 +/- 3.4 mV (P = not significant). In contrast, hypoperfused segments with a perfusion/metabolism match and nonviable segments showed significantly lower voltage (6.9 +/- 3.1 mV, P < 0.0001 and 4.1 +/- 1.1 mV, P < 0.0001 vs. normal). In hypoperfused segments, metabolic activity was more closely related to endocardial voltage than was myocardial perfusion (201Tl vs. voltage: r = 0.38, SEE = 3.2, P < 0.001; 18F-FDG PET vs. voltage: r = 0.6, SEE = 2.8, P < 0.0001). CONCLUSION: In hypoperfused myocardium, electrical activity by NOGA mapping is more closely related to PET metabolic activity than to SPECT myocardial perfusion. As NOGA mapping does not differentiate hypoperfused myocardium with enhanced glucose utilization from normal myocardium, results from NOGA mapping need to be correlated with results from perfusion imaging to identify hypoperfused, yet viable, myocardium and to stratify patients for revascularization procedures.     

Relation of myocardial perfusion at rest and during pharmacologic stress to the PET patterns of tissue viability in patients with severe left ventricular dysfunction

Background. Stress perfusion imaging can assess effectively the amount of jeopardized myocardium, but its use for identifying underperfused but viable myocardium has yielded variable results. We evaluated the relation between measurements of myocardial perfusion at rest and during pharmacologic stress and the patterns of tissue viability as determined by positron emission tomographic (PET) imaging.Methods and Results. We studied 33 patients with coronary artery disease and left ventricular (LV) dysfunction (LV ejection fraction, 30% ± 8%). PET imaging was used to evaluate regional myocardial perfusion at rest and during pharmacologic stress with [¹³N]-ammonia as a flow tracer, and to delineate patterns of tissue viability (ie, perfusion-metabolism mismatch or match) using [¹⁸F]-deoxyglucose (FDG). We analyzed 429 myocardial regions, of which 229 were dysfunctional at rest. Of these, 30 had normal perfusion and 199 were hypoperfused. A severe resting defect (deficit>40% below normal) predicted lack of significant tissue viability; 31 of 35 regions (89%) had a PET match pattern denoting transmural fibrosis. Although regions with mild or moderate resting defects (deficit <40% below normal) showed evidence of metabolic activity, perfusion measurements alone failed to identify regions with PET mismatch (reflecting hibernating myocardium). Reversible stress defects were observed with slightly higher frequency in regions with a PET mismatch (10 of 37) than in those with a PET match (36 of 162) pattern of viability. A reversible stress defect was a specific (78%) marker, but was a relatively insensitive marker (27%) of viable myocardium as defined by the PET mismatch pattern.Conclusions. In patients with LV dysfunction, the severity of regional contractile abnormalities correlates with the severity of flow deficit at rest. Severe reductions in resting blood flow in these dysfunctional regions identify predominantly nonviable myocardium that is unlikely to have improved function after revascularization. Although dysfunctional myocardium with mild to moderate flow reductions contains variable amounts of viable tissue (as assessed by FDG uptake), flow measurements alone do not distinguish between regions with PET mismatch (potentially reversible dysfunction) and PET match (irreversible dysfunction). The presence of an irreversible defect on stress imaging is a relatively specific (78%) marker of PET match, whereas a reversible stress defect is a rather insensitive (27%) marker of viability, as defined by the PET mismatch pattern.     

The kinetics of β-methyl-substituted labelled fatty acids in ischaemic myocardium: an analysis in man and with a blood-perfused isolated heart model

β-Methyl-substituted free fatty acids (FFAs) have been developed for myocardial single-photon emission tomography (SPET) imaging, but little is known about their kinetics in ischaemic conditions. The aim of this study was to determine the changes in the myocardial kinetics of a β-methyl-branched FFA, [¹²³I]16-iodo-3-methyl-hexadecanoic acid (MIHA), under ischaemic conditions. The kinetics of MIHA were analysed: (a) using a blood-perfused isolated heart model subjected to moderate ischaemia (50% flow reduction) and (b) in patients who had an exercise thallium-201 SPET defect corresponding to either necrotic (n = 13) or chronically ischaemic and viable (n = 15) myocardium, and who underwent two consecutive SPET studies after MIHA injection. In animals, the myocardial early retention fraction of MIHA, but not its clearance rate, was dependent on coronary flow, the early retention fraction being higher in ischaemic than in normoxic conditions (0.24±0.10 vs 0.14±0.04, P = 0.004). In the patient SPET studies, the uptake of MIHA calculated in ischaemic and viable areas (G1: 74%±9% of maximal left ventricular value) was different from that calculated in necrotic (G2: 59%±7%, P<0.001) or normal (G3: 88±6%, P<0.001) areas. By contrast, MIHA-clearance calculated between the two consecutive SPET studies was not different in G1, G2 and G3. Unlike in the case of other FFAs, the myocardial clearance of MIHA is not decreased by ischaemia. However, the early retention of MIHA is increased in the case of a moderate reduction in coronary flow, a property which might help in the detection of viability in chronically ischaemic myocardium. Received 3 November 1998 and in revised form 15 January 1999     

Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration

Background  Reversal of ischemia after myocardial infarction by revascularization is worth-while only if viability exists in a sufficiently large portion of the left ventricle. Methods and Results  To determine myocardial hypoperfusion reversibility and its influence on segmental and global function, we studied 50 patients after myocardial infarction. Three technetium 99m-tetrofosmin scintigraphies were performed: 1 at rest, 1 after 0.6 mg sublingual nitroglycerin (NTG), and 1 after injection at peak stress. First-pass multigated radionuclide angiography was obtained at rest and after NTG. Each patient also underwent a stress redistribution-reinjection thallium-201 scintigraphy. During stress ^99mTc-tetrofosmin, 104 segments had normal uptake, 51 showed moderately reduced uptake, and 186 had severely reduced uptake. Of these 186 segments, 33 (18%) improved at rest, and 41 (22%) improved only after NTG. Fifty-nine (79%) of these segments with improved uptake were also found to have reversible defects on ²⁰¹Tl imaging. In the 26 patients with ventricular dysfunction, a 73% agreement was found between the functional and ^99mTc-tetrofosmin uptake post-NTG improvement, whereas a 69% agreement was found with thallium reinjection. No significant differences were seen between ^99mTc-tetrofosmin and ²⁰¹Tl imaging. Conclusion  Nitroglycerin administration during ^99mTc-tetrofosmin scintigraphy improves the detection of myocardium with reversible hypoperfusion in patients with a previous myocardial infarction.     

Prognostic value of coronary angiography in patients with chronic ischemic left ventricular dysfunction and evidence of viable myocardium on thallium reinjection imaging

Background  We evaluated the independent and incremental prognostic value of cardiac catheterization and coronary angiographic data over thallium reinjection after stress redistribution imaging in patients with myocardial infarction and left ventricular dysfunction. Methods and Results  Sixty-nine patients with a first myocardial infarction (>8 weeks) and left ventricular ejection fraction ≤40% underwent thallium-201 reinjection after stress redistribution tomographic imaging and cardiac catheterization. During follow-up (mean 36 months) 11 cardiac events (8 cardiac deaths and 3 nonfatal myocardial infarctions) occurred. On Cox regression analysis independent predictors of cardiac events were the sum of reversible and moderately irreversible defects at thallium reinjection (χ², 16.4, p<0.005) and the number of reversible defects at stress redistribution (χ², 5.1, p<0.05). Moreover, thallium reinjection imaging improved the prognostic power of clinical, exercise, and stress redistribution data (p<0.01). The inclusion of left ventricular ejection fraction produced a borderline improvement (p=0.06), whereas the number of vessels with coronary disease did not. In contrast, in patients at high risk such as those with at least 25% of viable myocardium at reinjection, the number of diseased vessels provided additional prognostic information (p<0.05). Conclusions  In patients with chronic ischemic left ventricular dysfunction, left ventricular ejection fraction, but not the number of diseased vessels, provides additional prognostic information to thallium imaging. Therefore coronary angiography seems unnecessary in these patients, unless a significative amount of viable myocardium is detectable.     

Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: An alternative for determining myocardial viability

The identification of hibernating myocardium in patients with poor ventricular function has become increasingly important as investigators demonstrate an improvement in ventricular performance in patients with injured but viable myocardium who undergo surgical revascularization. Modifications of ²⁰¹Tl redistribution protocols and rest/stress ^99mTc-labeled hexakis-2-methoxy-2-methyl propylisonitrile perfusion studies continue to underestimate myocardial viability compared with resting ¹⁸F-labeled fluorodeoxyglucose (¹⁸FDG) positron emission tomography. The combined data from multiple investigators suggest that ¹⁸FDG single-photon emission computed tomograpy used in combination with cardiac perfusion agents, either sequentially or with simultaneous dual-isotope acquisition, may provide an acceptable alternative to positron emission tomographic imaging for the detection of hibernating myocardium.     

Exercise-rest Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: Direct comparison with Tl-201 reinjection

BACKGROUND: This study was designed to compare the results of exercise-rest technetium-99m tetrofosmin single photon emission computed tomography (SPECT) with those of thallium-201 reinjection at rest after exercise-redistribution imaging in the same patients with chronic ischemic left ventricular (LV) dysfunction. METHODS: Within 1 week, 33 patients with chronic myocardial infarction and LV dysfunction underwent exercise-rest tetrofosmin SPECT and Tl-201 reinjection at rest after exercise-redistribution imaging. In each patient, regional tetrofosmin and Tl-201 activity was quantitatively measured in 22 myocardial segments. Regional LV function was assessed in corresponding segments by echocardiography. RESULTS: Agreement in the evaluation of regional perfusion status between tetrofosmin and Tl-201 imaging was observed in 78% of the 726 total segments, with a kappa value of 0.61. In segments with normal function at echocardiography (n = 436), no difference between Tl-201 and tetrofosmin uptake was observed. In hypokinetic segments (n = 138), exercise tetrofosmin uptake was lower (P < .01) as compared with exercise Tl-201 activity, whereas no difference was observed between tetrofosmin uptake at rest as compared with Tl-201 activity on redistribution and reinjection images. In segments with severe functional impairment (akinetic or dyskinetic, n = 152), tetrofosmin uptake on exercise images was reduced (P < .01) as compared with exercise Tl-201 activity; furthermore, tetrofosmin uptake at rest was lower (P < .01) as compared with Tl-201 activity on both redistribution and reinjection images. In these segments, concordance in the detection of myocardial viability between tetrofosmin and Tl-201 imaging was observed in 138 (91%) of the 152 segments, with a kappa value of 0.77. CONCLUSIONS: In patients with chronic coronary artery disease and LV dysfunction quantitative exercise-rest tetrofosmin and Tl-201 reinjection SPECT provide similar information in the assessment of perfusion status and in the detection of myocardial viability.     

双核素心肌显像检测存活心肌的对比研究

目的 对比多巴酚丁胺负荷201Tl/静息99Tcm-甲氧基异丁基异腈(MIBI)双核素同步心肌断层显像及多巴酚丁胺负荷-再分布/再注射201Tl心肌断层显像法检测存活心肌的作用.方法 对160例临床怀疑有冠心病的患者予静息状态下静脉注射740 MBq99Tcm-MIBI,休息15 min后进行多巴酚丁胺负荷试验,在达到终止指标时静脉注射111 MSq201TICI.注射后观察5-lO min,分别行早期(10 min)、延迟(3 h)99Tcm-MIBI和201Tl双核素同步心肌断层显像.对早期负荷201Tl图像发现放射性缺损,延迟再分布201Tl和静息99Tcm-MIBI图像未见放射性填充的患者再注射37 MBq201TICI,30min后行再注射心肌灌注显像.负荷枷201Tl图像示放射性缺损,静息99Tcm-MIBI、再分布201Tl及再注射201Tl图像中发现任何一种放射性填充者均为存活心肌.断层显像后2周内全部患者进行了冠状动脉造影.采用SAS 6.12软件进行x2检验.结果 (1) 160例患者冠状动脉造影均发现冠状动脉狭窄.其中单支病变76例、双支病变5l例、三支病变33例.(2)152例多巴酚丁胺负荷201Tl图像发现放射性缺损的患者中,63例201Tl再分布和静息99Tcm-MIBI图像均发现放射性填充,5例201Tl再分布发现放射性填充而静息99Tcm-MIBI图像未见放射性填充,9例静息99Tcm-MIBI图像发现放射性填充而2001Tl再分布未见放射性填允,75例201Tl再分布和静息99Tcm-MIBI图像均未发现放射性填充,负荷201Tl-延迟再分布显像(66.0%,68/103)和负荷201Tl/静息99Tcm-MIBI显像(69.9%,72/103)鉴别存活心肌的灵敏度差异无统计学意义(x2=O.36,P>0.05).(3)75例201Tl再分布和静息99Tcm-MIBI图像均未发现放射性填充患者中,再注射201Tl显像后有26例放射性填充,再注射201Tl显像较单纯201Tl再分布或静息99Tcm-MIBI显像多检测出34.7%(26/75)患者有存活心肌.(4)8例多巴酚丁胺负荷201Tl、201Tl再分布图像和静息99Tcm-MIBI图像均未发现放射性稀疏,为假阴性,其中3例为三支冠状动脉病变,1例为双支冠状动脉病变(狭窄分别为90%及60%),3例为单支冠状动脉病变(狭窄<75%2例,85%1例),1例冠状动脉闭塞后有充分的侧枝循环.结论 多巴酚丁胺负荷-再分布/再注射201Tl心肌断层显像鉴别存活心肌优于多巴酚丁胺负荷201Tl/静息99Tcm-MIBI双核素同步心肌断层显像,是一种有效、无创的鉴别存活心肌的方法.     

Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization

Background

Assessment of viable myocardium in territories of hypoperfused myocardium is important for predicting functional recovery after revascularization. This study was designed to evaluate quantitative analysis of ^99mTc-labeled 2-methoxyisobutyl isonitrile (MIBI) myocardial perfusion imaging combined with isosorbide dinitrate (ISDN) infusion to detect myocardial viability in patients with chronic coronary artery disease before and after revascularization.

Methods and Results

Twenty-seven consecutive patients with previous myocardial infarction and left ventricular dysfunction (left ventricular ejection fraction 35.2%±13.5%) referred for coronary artery bypass (CABG) were studied with ^99mTc-labeled MIBI single-photon emission computed tomograpy at rest and during ISDN infusion before CABG followed by resting imaging after CABG. Quantitative analysis was performed with circumferential profiles. Left ventricular function (global and regional) was assessed by radionuclide ventriculography before and after CABG. Out of 212 abnormal perfusion segments with resting ^99mTc-labeled MIBI SPECT, 99 segments (47%) showed improved uptake of ^99mTc-labeled MIBI during ISDN infusion. The mean ratio of myocardial uptake was 0.58±0.25 (resting 0.53±0.23; p<0.05). After CABG, of 212 segments with hypoperfusion, 108 segments (51%; p>0.05 vs ISDN) showed improved uptake of ^99mTc-labeled MIBI. The mean ratio of myocardial uptake was 0.60±0.26 (resting 0.53±0.23; p<0.05). The concordance between the improvement of post-CABG wall motion and that of pre-CABG ISDN perfusion imaging was 83%, between the improvement of wall motion and perfusion imaging after CABG 94%, and between the improvement of pre-CABG ISDN and post-CABG perfusion imaging 83%, respectively.

Conclusion

ISDN infusion can improve the uptake of ^99mTc-labeled MIBI in hypoperfused myocardium and increase the efficiency of ^99mTc-labeled MIBI in the detection of viable myocardium in patients with previous myocardial infarction and left ventricular dysfunction.     

Prospective evaluation of thallium-201 reinjection in single-vessel coronary patients undergoing coronary bypass surgery

Twenty-two patients with single-vessel left anterior descending coronary artery disease were investigated by means of dipyridamole stress thallium-201 myocardial perfusion scintigraphy, using single photon emission tomography (SPET), 1 week before and 2–5 weeks after coronary bypass surgery. The dose of dipyridamole was 0.56 mg/kg, and the injected activity of ²⁰¹T1 was 74 MBq. Before surgery, and after completion of the redistribution study, a further 37 MBq of ²⁰¹T1 was injected. Ten minutes and 1 h later, repeated SPET imaging were performed. SPET images were evaluated both subjectively and semiquantitatively, using a five-grade segmental defect score system, with higher scores for more severe perfusion defects. Before surgery, the 3-h redistribution images revealed complete or partial persistence of the perfusion defects in all patients. On the images taken 10 min after reinjection, these defects were completely filled in four cases, and partially filled in ten cases. Further positive changes were observed on the 1-h post-reinjection images in four cases. Three of the 1-h post-reinjection images exhibited a paradox redistribution. The stress images after surgery corresponded well to the ²⁰¹T1 distribution on the preoperative 1-h post-reinjection images in 11 cases. The average of the segmental defect severity scores was 17.0 after stress, 10.1 at rest, 7.1 10 min after reinjection and 6.4 1 h after reinjection. After surgery, the average of both the post-stress and the 3-h redistribution scores was 3.1. The correlation coefficients between the segmental scores of the postoperative resting study and the preoperative 3-h resting and the 10-min and 1-h post-reinjection studies were 0.72, 0.69 and 0.78, respectively. It is concluded that post-reinjection ²⁰¹T1 images before surgery are good predictors of myocardial perfusion after revascularization. The best results are obtained if imaging is performed 1 h after reinjection. Correspondence to: J. Mester     

缺血心肌动物模型PET和SPECT显像及组织学对比研究

目的评估^201TI SPECT及^18F-脱氧葡萄糖（FDG）PET显像对模型猪心肌活力的鉴别。方法健康家猪12头，其中10头于冠状动脉左旋支起始处放置Ameriod环，饲养28d形成慢性心肌缺血动物模型（另2头作正常对照），行^201TI SPECT心肌灌注显像和^18F—FDG PET心肌代谢显像并与HE染色病理学改变进行比较。结果81个心肌节段中，^18F—FDG心肌显像示心肌有活力的节段为73个（90．1％），明显高于^201TI心肌显像所示的62个（76．5％），差异有显著性（P〈0．05）。HE染色结果示有心肌活力的节段为74个（91．3％），与^18F—FDG心肌显像所示结果差异无显著性（P〉0．05）。结论^18F—FDGPET心肌显像检测心肌活力的准确性明显高于^201TI SPECT心肌显像。     

Relation between myocardial uptake of thallium-201 chloride and fluorine-18 fluorodeoxyglucose imaged with single-photon emission tomography in normal individuals

Recently, we have demonstrated the feasibility of imaging myocardial uptake of fluorine-18 fluorodeoxyglucose (FDG) with single-photon emission tomography (SPET) using a specially designed collimator. Thallium-201 was used to determine distribution of perfusion for comparison with FDG uptake. However, regional²⁰¹Tl and FDG activities may be different, based on differences in tracer attenuation and the use of different collimators. To study the relation between tracer activities imaged with SPET, nine healthy individuals underwent resting²⁰¹Tl SPET and FDG SPET during a hyperinsulinaemic euglycaemic clamp. The SPET data were analysed semiquantitatively, using circumferential profiles. Mean profiles of midventricular short-axis slices showed no significant difference between²⁰¹Tl and FDG activity. Regional fluctuations were similar for FDG and²⁰¹Tl; the highest tracer activities were observed in the lateral wall and the lowest activities in the septum. Finally, pooled data (n=1620 segmental activities) in nine individuals showed a linear correlation (P<0.0001) between²⁰¹Tl and FDG activity: FDG=0.76²⁰¹Tl + 0.23 (r=0.70). These data demonstrate the absence of major differences between regional²⁰¹Tl and FDG activity in normal myocardium, suggesting that no separate²⁰¹Tl and FDG SPET reference values are needed for comparison with patient studies.     

Assessment of myocardial viability with a positron coincidence gamma camera using fluorodeoxyglucose in comparison with dedicated PET

The use of dual-head gamma camera modified positron coincidence detection (PCD) is a new, alternative method of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) imaging. This study investigated the potential ability of evaluating myocardial viability in patients with ischaemic heart disease by FDG imaging using PCD. A total of 21 patients (18 male, three female; mean age 59.7+/-8.5 years) with a history of previous myocardial infarction and confirmed coronary angiography underwent FDG PCD and FDG PET after oral glucose loading (75 g). Quantitative analysis was compared between images of FDG PCD and FDG PET. A significant linear correlation between the segmental percentage of FDG uptake obtained by PCD and PET was observed (r=0.63, P<0.001). By receiver operating characteristic (ROC) analysis, using FDG PET as the 'gold standard', at the 50% threshold value in PET, FDG PCD showed a sensitivity of 92% and specificity of 63% in detecting myocardial viability. Regional analysis showed lower agreement of FDG PCD and FDG PET in the inferior (79%) and septal (70%) walls compared with the other walls. Quantitative evaluation of myocardial viability using FDG PCD yielded comparable clinical results in apex, anterior and lateral walls to that of FDG PET. However, the agreement was lower in the inferior and septal walls. Therefore, results of FDG PCD should be carefully interpreted in evaluating myocardial viability in the inferior and septal walls. The application of a measured attenuation correction and scatter correction are needed to improve the detectability of myocardial viability in FDG imaging by coincidence gamma camera.